Cargando…

Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer

Argininosuccinate synthetase 1 (ASS1) is a rate-limiting enzyme in arginine biosynthesis. Although ASS1 expression levels are often reduced in several tumors and low ASS1 expression can be a poor prognostic factor, the underlying mechanism has not been elucidated. In this study, we reveal a novel as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohshima, Kenji, Nojima, Satoshi, Tahara, Shinichiro, Kurashige, Masako, Hori, Yumiko, Hagiwara, Kohei, Okuzaki, Daisuke, Oki, Shinya, Wada, Naoki, Ikeda, Jun-ichiro, Kanai, Yoshikatsu, Morii, Eiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371991/ https://www.ncbi.nlm.nih.gov/pubmed/28358054 http://dx.doi.org/10.1038/srep45504

Ejemplares similares

Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma
por: Tahara, Shinichiro, et al.
Publicado: (2021)

Serum deprivation‐response protein regulates aldehyde dehydrogenase 1 through integrin‐linked kinase signaling in endometrioid carcinoma cells
por: Tahara, Shinichiro, et al.
Publicado: (2019)

S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the “MELF” pattern
por: Tahara, Shinichiro, et al.
Publicado: (2016)

FAM111B enhances proliferation of KRAS‐driven lung adenocarcinoma by degrading p16
por: Kawasaki, Keisuke, et al.
Publicado: (2020)

Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation
por: Kurashige, Masako, et al.
Publicado: (2018)

An immature inhibin‐α‐expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis
por: Kusumoto, Shinya, et al.
Publicado: (2021)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma
por: Tone, Mitsuyo, et al.
Publicado: (2020)

CUBIC pathology: three-dimensional imaging for pathological diagnosis
por: Nojima, Satoshi, et al.
Publicado: (2017)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

Leishmania donovani Argininosuccinate Synthase Is an Active Enzyme Associated with Parasite Pathogenesis
por: Lakhal-Naouar, Ines, et al.
Publicado: (2012)

Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
por: Miyamoto, Takafumi, et al.
Publicado: (2017)

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
por: Savaraj, Niramol, et al.
Publicado: (2015)

Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
por: Locke, Matthew, et al.
Publicado: (2016)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine endometrioid adenocarcinoma
por: ZHAN, MAOSHENG, et al.
Publicado: (2016)

Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management
por: Sardar, Abul Hasan, et al.
Publicado: (2016)

Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency
por: Herrera Sanchez, Maria Beatriz, et al.
Publicado: (2017)

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
por: Feun, L G, et al.
Publicado: (2012)

DEPTOR in Skeletal Development and Diseases
por: Perez-Tejeiro, Jose Miguel, et al.
Publicado: (2021)

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
por: Syed, N, et al.
Publicado: (2013)

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines
por: Shan, Yan-Shen, et al.
Publicado: (2015)

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma
por: Thongkum, Angkana, et al.
Publicado: (2017)

The expression of trefoil factor 3 is related to histologic subtypes and invasiveness in lung adenocarcinoma
por: Luo, Wenjuan, et al.
Publicado: (2021)

Heterologous Expression of Argininosuccinate Synthase From Oenococcus oeni Enhances the Acid Resistance of Lactobacillus plantarum
por: Zhao, Hongyu, et al.
Publicado: (2019)

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
por: Zou, Zizheng, et al.
Publicado: (2021)

Retraction: Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management
Publicado: (2023)

Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression
por: Werner, Anke, et al.
Publicado: (2017)

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
por: Kelly, M P, et al.
Publicado: (2012)

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
por: Wu, Fe-Lin Lin, et al.
Publicado: (2011)

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
por: Delage, B, et al.
Publicado: (2012)

Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression
por: Kim, Stephanie S., et al.
Publicado: (2020)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

Deptor: not only a mTOR inhibitor
por: Catena, Valeria, et al.
Publicado: (2017)

Regulation of human mTOR complexes by DEPTOR
por: Wälchli, Matthias, et al.
Publicado: (2021)

Function of Deptor and its roles in hematological malignancies
por: Morales-Martinez, Mario, et al.
Publicado: (2021)

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
por: Liu, Jiangbo, et al.
Publicado: (2014)

Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
por: McAlpine, Jennifer A, et al.
Publicado: (2014)

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
por: Beddowes, Emma, et al.
Publicado: (2017)

Placental DEPTOR as a stress sensor during pregnancy
por: Mparmpakas, Dionisis, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i87qe9c8l5dq1nimevmcqngoov